These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2955602)

  • 1. [Transcutaneous pO2 and laser Doppler flux in increasing doses of intraarterial and intravenously administered prostaglandin E1].
    Creutzig A; Caspary L; Ranke C; Kiessling D; Wilkens J; Frölich J; Alexander K
    Vasa; 1987; 16(2):114-8. PubMed ID: 2955602
    [No Abstract]   [Full Text] [Related]  

  • 2. Transcutaneous PO2 and laser Doppler flowmetry in patients with arterial occlusive disease receiving intraarterial infusions of PGE1 or nucleotide phosphates.
    Caspary L; Creutzig A; Alexander K
    Prog Clin Biol Res; 1987; 242():433-8. PubMed ID: 2959965
    [No Abstract]   [Full Text] [Related]  

  • 3. [Double-blind placebo-controlled study of the behavior of tcPO2 during intravenous infusion of prostaglandin E1 in patients with severe arterial occlusive disease].
    Creutzig A; Caspary L; Alexander K
    Vasa Suppl; 1992; 35():36-8. PubMed ID: 1481055
    [No Abstract]   [Full Text] [Related]  

  • 4. Intra-arterial and intravenous administration of prostaglandin E1 cause different changes to skin microcirculation in patients with peripheral arterial occlusive disease.
    Thum J; Caspary L; Creutzig A; Alexander K
    Vasa; 1998 May; 27(2):100-5. PubMed ID: 9612114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intra-arterial administration of prostaglandin E1 in occlusive arterial diseases].
    Davidović L; Vranes M; Cernak I; Kostić D; Lovrić A; Sagić D; Lotina S
    Srp Arh Celok Lek; 1992; 120(1-2):9-14. PubMed ID: 1641706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skin oxygen pressure histograms in patients with peripheral arterial occlusive disease during intraarterial and intravenous prostaglandin E1 infusions of different dosages and their prognostic value.
    Creutzig A; Arnold A; Caspary L; Thum J; Alexander K
    Angiology; 1995 May; 46(5):357-67. PubMed ID: 7741319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraarterial perfusion of prostaglandin E1 after lumbar sympathectomy or reconstruction on femoropopliteal segment.
    Davidovic LB; Vranes MR; Lotina SI; Cernak IF; Velimirovic DB; Stojanov PL; Sindjelic RP; Sagic DZ; Cinara IS
    Int Angiol; 1991; 10(3):178-81. PubMed ID: 1765722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experience with intravenous prostaglandin E1 in stage II b arterial occlusive disease].
    Dé P; Hepp W
    Vasa Suppl; 1990; 30():139-41. PubMed ID: 2075565
    [No Abstract]   [Full Text] [Related]  

  • 9. [Intravenous and intra-arterial prostaglandin E1 treatment in patients with stage IIb arterial occlusive disease].
    Rudofsky G
    Vasa Suppl; 1988; 23():121-5. PubMed ID: 3206330
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prostaglandin E1 in intermittent claudication].
    Scheffler P; de la Hamette D; Rogatti W
    Vasa Suppl; 1992; 35():147-8. PubMed ID: 1481022
    [No Abstract]   [Full Text] [Related]  

  • 11. [Intravenous administration of PGE1: studies of the effectiveness and duration of the effect of various dosages based on flow measurements of the femoral artery in patients with healthy vessels and in stage IIb arterial occlusive disease].
    Scheffler P; Birkel L; Grub KR; de la Hamette D
    Vasa Suppl; 1988; 23():126-9. PubMed ID: 3061035
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of intra-arterial prostaglandin E1 in patients with peripheral arterial occlusive disease.
    Creutzig A; Creutzig H; Alexander K
    Eur J Clin Invest; 1986 Dec; 16(6):480-5. PubMed ID: 3104047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Randomized study comparing the clinical effectiveness of intravenous prostaglandin E1 and intravenous pentoxifylline in patients with Fontaine stage IIb arterial occlusive disease].
    Hepp W; von Bary S; Corovic D; Diehm C; Mühe E; Rudofsky G; Scheffler P; Trübestein G; Vogelpohl M
    Vasa Suppl; 1991; 33():348-9. PubMed ID: 1788753
    [No Abstract]   [Full Text] [Related]  

  • 14. [Long-term blood pressure measurements with i.v. prostaglandin E1 infusion].
    Heidrich H; Brodel C; Meuche C; Hellmann G; Ranft J
    Vasa Suppl; 1989; 27():46. PubMed ID: 2623542
    [No Abstract]   [Full Text] [Related]  

  • 15. Intraarterial prostaglandine E1 in arterial occlusive disease (AOD) stages III and IV.
    Herold A; Bruch HP; Hörl M; Düsel W
    Prog Clin Biol Res; 1987; 242():439-44. PubMed ID: 2959966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Placebo controlled, double-blind study of the effectiveness of i.v. prostaglandin E1 in diabetic patients with stage IV arterial occlusive disease].
    Stiegler H; Diehm C; Grom E; Martin M; Mörl H; Rudofsky G; Vogelberg KH
    Vasa Suppl; 1992; 35():164-6. PubMed ID: 1481031
    [No Abstract]   [Full Text] [Related]  

  • 17. Therapeutic efficacy of intravenously applied prostaglandin E1.
    Scheffler P; de la Hamette D; Leipnitz G
    Vasa Suppl; 1989; 28():19-25. PubMed ID: 2609240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Metabolism of intravenously administered prostaglandin E1 in patients with peripheral arterial occlusive disease].
    Hesse WH; Rudofsky G; Peskar BA
    Wien Klin Wochenschr; 1991; 103(18):554-7. PubMed ID: 1750222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reaction of transcutaneous PO2 and laser Doppler flow signal on intraarterial infusion of PGE1 and nucleotide phosphates in patients with peripheral arterial occlusive disease.
    Caspary L; Creutzig A; Alexander K
    Vasa Suppl; 1987; 17():17-22. PubMed ID: 3470960
    [No Abstract]   [Full Text] [Related]  

  • 20. [Mechanisms of action of prostaglandin E1 in therapy of peripheral arterial occlusive diseases].
    Weiss T
    Vasa; 2003 Nov; 32(4):187-92. PubMed ID: 14694766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.